Thank you VJHemOnc and thanks BSH - Haematology for inviting exercise and lifestyle medicine into the annual conference stream 2024 - exercise matters for rehab and recovery in haematological cancers Moving Medicine Faculty of Sport and Exercise Medicine UK

🎥 Alexander Lyon of Royal Brompton and Harefield gives a wonderful overview of the European Society of Cardiology guidelines on cardio-oncology, highlighting how to incorporate the guidelines into clinical practice:

👉 ow.ly/kQWk50RHZHe

#BSH2024 #HemOnc BSH - Haematology

We’re eagerly counting down the days until #COMy24 – taking place this week in Paris, France!

We’re delighted to bring you exciting updates from leading #MultipleMyeloma experts at VJHemOnc.com – watch this space!

COMy #HemOnc #MMsm

Join us for our Post-ASCO & EHA 2024 #SickleCell Disease Highlights 📣 🩸

🌟 Chaired by Dr Subarna Chakravorty

Featuring presentations & panel discussions on selected abstracts from #ASCO & #EHA 2024 🔦

REGISTER 👉 us06web.zoom.us/webinar/regist…

#EHA 2024 #ASCO 24

How can MRD be used to guide post-alloSCT treatment decisions in AML?
Felicitas Thol (Medizinische Hochschule Hannover) provides an insight into this in a recent interview.

Watch here:

👉 ow.ly/IX1150RI1hk

#Leusm #AMLsm #Leukemia #HemOnc #EBMT2024 #BMTsm The EBMT

Exercise plays an important role in cancer prevention & has a host of benefits for patients during & after treatment. 🏃

We heard from Rebecca Robinson (@mhglondon) on why exercise remains an underutilized tool in routine care:

👉 ow.ly/CPfC50RI1Sq

#HemOnc #SuppOnc #BSH2024

Great job guys NYU Langone Health

At #BSH2024 , we heard from Thomas Coats (Royal Devon NHS) on the future role of AI models in #Hematology and the need for high-quality data sets to make their use feasible . 💭

Watch the interview here:
👉 ow.ly/IKjz50RI0FE

#HemOnc #OncoRad BSH - Haematology

Check out our latest podcast featuring Anna Sureda and Manali Kamdar!

They discuss #CART and bispecific antibody therapy in #NonHodgkinLymphoma , the risk of secondary malignancies, and the optimal sequencing of these agents.

Listen here: 👉ow.ly/Lmcp50RIIcy👈

We’re so excited! Only❗two weeks❗to go until #ASCO24 !

From May 31st we’ll be interviewing #HemOnc experts – to discover the latest in cancer treatment innovations head to → vjhemonc.com ←

ASCO VJHemOnc

Genomics & proteomics continue to play a valuable role in multiple myeloma. 🧬

Check out this discussion ft. Gareth Morgan, Sarah Gooding, Francesco Maura & Arun Wiita from #iwMyeloma24 :

📽️ ow.ly/8qk150RBanR

#MMsm #HemOnc

We are excited to announce that, in just under a month, we will be attending #EHA2024 in Madrid, Spain! 🇪🇸

We can't wait to interview leading experts on the latest updates in #HemOnc & #Hematology ! 🩸

Register here and join us:
👉 ow.ly/mIOh50RGGSl 👈

European Hematology Association

It was fantastic to catch up with Wendy Osborne (Newcastle Hospitals) recently and hear about the role of bispecific antibodies in the treatment landscape of R/R #DLBCL .

Watch the interview here:
👉 ow.ly/QvIK50RAsgF 👈

#LYMsm #Lymphoma #HemOnc #ImmunoOnc #EBMT2024 The EBMT

The importance of nutrition in #Hematology and cancer care is often overlooked.🍎🍽️

In a recent interview, shireen kassam (@KingsCollegeLon) comments on nutrition as a key tool when treating patients:

👉 ow.ly/lt6F50RAoaG

#HemOnc #SuppOnc #BSH2024 BSH - Haematology

Only 1 week to go until the 10th COMy World Congress!

Don’t miss out - from May 23rd to 26th we’ll be interviewing leading experts and providing exclusive coverage on all things #MultipleMyeloma .

Stay tuned on 👉VJHemOnc.com👈

COMy #COMy24 #MMsm #HemOnc

Join us for our Post-ASCO & EHA 2024 Highlights 📣 🩸

Featuring presentations & panel discussions on selected abstracts from #ASCO & #EHA 2024 🔦

REGISTER 👉 vjhemonc.com/feature/post-a…

#EHA 2024 #ASCO 24 Claire Harrison Shaji Kumar Naval Daver, M.D. Anna Sureda Matthew Davids, MD, MMSc Amer Zeidan MBBS,MHS ‏عامر زيدان

Thanks VJHemOnc for this chance to explain JTH article where with Caroline Dix & Gerry Dolan we review the need for primary prevention of atherosclerosis in those with Haemophilia

Not long to go until #ISA2024 ! 🩸

The VJHemOnc team are so excited to be attending onsite, where we'll be interviewing experts on the latest developments in #amyloidosis .

Follow us for more updates soon!

The International Society Of Amyloidosis #ISA_2024 #HemOnc

Watch this fantastic discussion w/ C. Ola Landgren, M.D., Suzanne Lentzsch, MD, PhD, Suzanne Trudel & Tom Martin, who discuss:

- The use of bisphosphonates for bone disease
- Updates w/ the use of isatuximab & belamaf
- The value of MRD as a surrogate endpoint:

➡️ ow.ly/NtfN50RBa0T

#MMsm

Having #hemophilia does not protect patients against atherosclerosis.

Therefore, primary prevention is key in this population, and optimal strategies are being investigated.

Hear more from Prof. Beverley Hunt (Professor Beverley Hunt OBE):
👉 ow.ly/iVkZ50RAoUY

#Hematology #BSH2024